bioRxivCancer BiologyPreprint
CYCLON is a nucleolar protein that regulates pan-cancer cell fitness through ribosome biogenesis
Andrea Cecilia Garcia-SandovaliD, Sébastien DurandiD, Nic RobertsoniD, Sieme HamaidiaiD, Jan MikolajczykiD, Fleur BourdelaisiD, Émilie MontautiD, Victoria Lopez, Tomasz W. TurowskiiD, David W. TollerveyiD, Jean‐Jacques DiaziD, Olivier DestaingiD, Anouk EmadaliiD
Abstract
Tumor progression is driven by cancer cell fitness, defined as the capacity of malignant cells to maintain growth, adapt to stress and withstand therapy Cellular fitness is fundamentally governed by nucleolar processes, which act as central regulators by integrating RNA processing with ribosome biogenesis to support protein synthesis and stress adaptation. The nuclear protein CYCLON, containing a large intrinsically disordered region (IDR) could be implicated in mediating biomolecular condensates and regulatory plasticity, which are key elements of nucleolar biology. CYCLON also emerged as a candidate regulator of cancer cell fitness, as it is frequently overexpressed across tumor types. Inducible silencing and cell biology approaches have shown that CYCLON maintains nucleolar integrity, controls nucleoli size and number, nucleolin and Ki-67 distribution and prevents nucleolar stress. CYCLON contributes to ribosome biogenesis by binding ribosomal RNA (rRNA) and regulating 32S and 21S pre-rRNA processing, ultimately influencing ribosomal subunit production and global protein synthesis. Its depletion impairs proliferation and clonogenic capacity by prolonging both interphase and mitosis, leading to slowed cell cycle progression. The impact of CYCLON on cellular fitness has been consistently observed across cancer models, reinforcing its essential role in the regulation of nucleolar biology.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBC
Joseph Mills, Anna Tessari, … Dario Palmieri·Journal of Experimental & Clinical Cancer ResearchPeer-reviewed·Jul 14, 2025
- Disruption of nucleolar integrity triggers cellular quiescence through organelle rewiring and secretion
Prashant Rawat, Tabea Quaderer, … Matthias Peter·bioRxiv·Aug 28, 2025
- From Flies to Humans: A Conserved Role of CEBPZ, NOC2L, and NOC3L in rRNA Processing and Tumorigenesis.
Guglielmo Rambaldelli, Valeria Manara, … Paola Bellosta·bioRxiv·Jan 11, 2025
- A pre-rRNA positive feedback loop drives malignant ribosome biogenesis
Emilie L. Alard, Martin Dodel, … Faraz K. Mardakheh·bioRxiv·Jul 3, 2026
- An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
M. S. Azman, M. Dodel, … F. K. Mardakheh·bioRxiv·Dec 16, 2021
- A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growth
I. Zuazo-Gaztelu, D. Lawrence, … A. Ashkenazi·bioRxiv·Nov 22, 2023